论文信息 - Recombinant human FGF-2 for the treatment of early-stage osteonecrosis of the femoral head: TRION, a single-arm, multicenter, Phase II trial. - 字舞流文

Recombinant human FGF-2 for the treatment of early-stage osteonecrosis of the femoral head: TRION, a single-arm, multicenter, Phase II trial.

Sakae Tanaka | N. Sugano | S. Matsuda | H. Akiyama | S. Morita | H. Hamada | A. Kaneuji | Y. Kuroda | M. Takagi | Y. Inaba | Takeyuki Tanaka | Yusuke Fujimoto | T. Ito-Ihara | Hiroyasu Abe | Tomonori Tetsunaga | Daisuke Takahashi | Takaki Miyagawa | Ryuta Asada